TUNITAS THERAPEUTICS
Tunitas Therapeutics is a privately held biopharmaceutical company that is poised to develop unique and precisely targeted protein therapeutics that will dramatically change the lives of allergy sufferers. With Tunitas’ proteins, patients receive a treatment regimen in their allergist’s office that will alter the natural course of their disease, providing a therapeutic option with long-lasting benefit.
TUNITAS THERAPEUTICS
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2008-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.tunitastherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
(650)887-4747
Email Addresses:
[email protected]
Total Funding:
10 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF LetsEncrypt Nginx DoubleClick.Net CloudFront Google Adsense AdBlock Acceptable Ads Google Adsense For Domains
Similar Organizations
Accent Therapeutics
Accent Therapeutics is a biopharmaceutical company.
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Cerebral Therapeutics
Cerebral Therapeutics is a clinical-stage pharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Akashi Therapeutics
Akashi Therapeutics is a clinical stage biopharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Investors List
RA Capital Advisors LLC
RA Capital Advisors LLC investment in Series A - Tunitas Therapeutics
WuXi Healthcare Ventures
WuXi Healthcare Ventures investment in Series A - Tunitas Therapeutics
Ally Bridge Group
Ally Bridge Group investment in Series A - Tunitas Therapeutics
Official Site Inspections
http://www.tunitastherapeutics.com
- Host name: 172.67.142.237
- IP address: 172.67.142.237
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Tunitas Therapeutics"
Tunitas Therapeutics | INNOVATIVE THERAPIES FOR ALLERGIC …
Tunitas is dedicated to the discovery and development of novel therapeutics designed to transform the treatment of patients with serious allergic diseases.See details»
MANAGEMENT TEAM | Tunitas Therapeutics
Dr. King is Tunitas’ Senior VP of Research, responsible for the company’s research and preclinical activities. Previously, he was the Chief Scientific Officer at AnaptysBio where he led …See details»
HISTORY - Tunitas Therapeutics
The company’s core technology is exclusively licensed from the University of California, Los Angeles (UCLA), where it was developed in the laboratory of Dr. Andrew Saxon, one of the …See details»
Tunitas Therapeutics - Crunchbase Company Profile
Tunitas Therapeutics is a privately held biopharmaceutical company. PRNewswire UK All — Research and Markets - Global Allergy …See details»
Tunitas Therapeutics 2025 Company Profile: Valuation, Funding ...
Tunitas Therapeutics was founded in 2007. Where is Tunitas Therapeutics headquartered? Tunitas Therapeutics is headquartered in South San Francisco, CA. What industry is Tunitas …See details»
TUNITAS THERAPEUTICS, INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for TUNITAS THERAPEUTICS, INC. of Los Altos, CA. Get the latest business insights from Dun & Bradstreet.See details»
Tunitas Therapeutics Inc - Company Profile and News
Company profile page for Tunitas Therapeutics Inc including stock price, company news, executives, board members, and contact informationSee details»
TUNITAS THERAPEUTICS, INC. - VentureRadar
Tunitas Therapeutics, Inc. (San Francisco) is a privately held biopharmaceutical company that is developing novel and precisely targeted protein therapeutics with the potential to dramatically …See details»
Contact Us - Tunitas Therapeutics
INNOVATIVE THERAPIES FOR ALLERGIC DISEASESSee details»
Tunitas Therapeutics Company Profile | Management and
Tunitas Therapeutics, Inc. (South San Francisco) is dedicated to the discovery and development of novel therapeutics designed to transform the treatment of patients with serious allergic …See details»
TUNITAS THERAPEUTICS, INC. Overview - SignalHire
TUNITAS THERAPEUTICS, INC. is a private company that has been in the industry for 15 years. The position of the President & CEO is occupied by Nolan Sigal. Its headquarters is located at …See details»
Firm | SBIR
Tunitas Therapeutics, Inc. has negotiated an exclusive license with the University of California to develop chimeric allergen-Fc(1 proteins for the treatment of food allergy. The current proposal …See details»
Tunitas Therapeutics - 2025 Company Profile - Tracxn
May 6, 2025 Tunitas Therapeutics is a deadpooled company based in San Francisco (United States), founded in 2008. It operates as a Protein Therapies for Allergic Diseases. Tunitas …See details»
Tunitas Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
May 8, 2025 The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase …See details»
SCIENTIFIC ADVISORS - Tunitas Therapeutics
A founder and CSO of Tunitas, Dr. Saxon is Professor and former Chief of Clinical Immunology and Allergy at the UCLA School of Medicine. Dr. Saxon is a world-renowned expert in the …See details»
Tunitas Therapeutics Inc.
Tunitas Therapeutics Inc. thinks its research could go a long way toward relieving the suffering of the 40% of Americans with allergies to one or more common inhalant or food allergan. The …See details»
INVESTORS - Tunitas Therapeutics
INNOVATIVE THERAPIES FOR ALLERGIC DISEASESSee details»
BOD | Tunitas Therapeutics
Dr. Nikodem has more than 13 years of experience in capital markets and financial analysis of biotechnology and healthcare companies. As a senior representative of Ally Bridge Group …See details»
Tunitas Therapeutics - Overview, News & Similar companies
Who is Tunitas Therapeutics. Tunitas Therapeutics, Inc. (South San Francisco) is dedicated to the discovery and development of novel therapeutics designed to transform the trea tment of …See details»
PRESS RELEASES | Tunitas Therapeutics
Tunitas Therapeutics Expands Board of Directors with Appointment of Dr. Mervyn Turner. Tunitas Therapeutics Appoints David J. King as Senior Vice President, Research. Tunitas …See details»